Cargando…

Pancreatic Cancer Research beyond DNA Mutations

Pancreatic ductal adenocarcinoma (PDAC) is caused by genetic mutations in four genes: KRAS proto-oncogene and GTPase (KRAS), tumor protein P53 (TP53), cyclin-dependent kinase inhibitor 2A (CDKN2A), and mothers against decapentaplegic homolog 4 (SMAD4), also called the big 4. The changes in tumors ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Hiromichi, Sasaki, Kazuki, Hara, Tomoaki, Tsuji, Yoshiko, Arao, Yasuko, Otsuka, Chihiro, Hamano, Yumiko, Ogita, Mirei, Kobayashi, Shogo, di Luccio, Eric, Hirotsu, Takaaki, Doki, Yuichiro, Eguchi, Hidetoshi, Satoh, Taroh, Uchida, Shizuka, Ishii, Hideshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599774/ https://www.ncbi.nlm.nih.gov/pubmed/36291712 http://dx.doi.org/10.3390/biom12101503

Ejemplares similares

Multifaced roles of desmoplastic reaction and fibrosis in pancreatic cancer progression: Current understanding and future directions
por: Sato, Hiromichi, et al.
Publicado: (2023)

Drug Discovery and Development of miRNA-Based Nucleotide Drugs for Gastrointestinal Cancer
por: Sato, Hiromichi, et al.
Publicado: (2023)

Targeting the regulation of aberrant protein production pathway in gastrointestinal cancer treatment
por: Sato, Hiromichi, et al.
Publicado: (2022)

EpisomiR, a New Family of miRNAs, and Its Possible Roles in Human Diseases
por: Arao, Yasuko, et al.
Publicado: (2022)

RNA Modification in Inflammatory Bowel Diseases
por: Nakayama, Mika, et al.
Publicado: (2022)

Application of C. elegans cancer screening test for the detection of pancreatic tumor in genetically engineered mice
por: Ueda, Yuji, et al.
Publicado: (2019)

Emerging roles of long noncoding and circular RNAs in pancreatic ductal adenocarcinoma
por: Sato, Hiromichi, et al.
Publicado: (2022)

Role of RNA methylation in the regulation of pancreatic cancer stem cells (Review)
por: Tsuji, Yoshiko, et al.
Publicado: (2023)

COVID-19 Drug Discovery Using Intensive Approaches
por: Asai, Ayumu, et al.
Publicado: (2020)

State-of-the-Art Technology of Model Organisms for Current Human Medicine
por: Konno, Masamitsu, et al.
Publicado: (2020)

Impact of One-Carbon Metabolism-Driving Epitranscriptome as a Therapeutic Target for Gastrointestinal Cancer
por: Takeda, Yu, et al.
Publicado: (2021)

Cancer metabolism challenges genomic instability and clonal evolution as therapeutic targets
por: Takeda, Yu, et al.
Publicado: (2022)

Convolutional Neural Network Can Recognize Drug Resistance of Single Cancer Cells
por: Yanagisawa, Kiminori, et al.
Publicado: (2020)

Immuno-Surgical Management of Pancreatic Cancer with Analysis of Cancer Exosomes
por: Takeda, Yu, et al.
Publicado: (2020)

Nematode-Applied Technology for Human Tumor Microenvironment Research and Development
por: di Luccio, Eric, et al.
Publicado: (2022)

Drug discovery of anticancer drugs targeting methylenetetrahydrofolate dehydrogenase 2
por: Asai, Ayumu, et al.
Publicado: (2018)

The potential clinical utility of cell-free DNA for gastric cancer patients treated with nivolumab monotherapy
por: Inagaki, Chiaki, et al.
Publicado: (2023)

Characteristics of early‐onset pancreatic cancer and its association with familial pancreatic cancer and hereditary pancreatic cancer syndromes
por: Eguchi, Hidetoshi, et al.
Publicado: (2020)

Epithelial Cell Transformation and Senescence as Indicators of Genome Aging: Current Advances and Unanswered Questions
por: Kitakaze, Masatoshi, et al.
Publicado: (2021)

Computational trans-omics approach characterised methylomic and transcriptomic involvements and identified novel therapeutic targets for chemoresistance in gastrointestinal cancer stem cells
por: Konno, Masamitsu, et al.
Publicado: (2018)

C. elegans as a Powerful Tool for Cancer Screening
por: di Luccio, Eric, et al.
Publicado: (2022)

State-of-the-Art Cancer Biology, Biodiagnostics and Therapeutics in Japan
por: Yamaguchi, Junichi, et al.
Publicado: (2023)

Comprehensive profiling of novel epithelial–mesenchymal transition mediators and their clinical significance in colorectal cancer
por: Ishikawa, Satoshi, et al.
Publicado: (2021)

Clinical outcomes of neoadjuvant chemotherapy for resectable colorectal liver metastasis with intermediate risk of postoperative recurrence: A multi‐institutional retrospective study
por: Noda, Takehiro, et al.
Publicado: (2022)

Distinct methylation levels of mature microRNAs in gastrointestinal cancers
por: Konno, Masamitsu, et al.
Publicado: (2019)

Mitochondrial pyruvate carrier 1 expression controls cancer epithelial‐mesenchymal transition and radioresistance
por: Takaoka, Yuji, et al.
Publicado: (2019)

Multicentre biomarker cohort study on the efficacy of nivolumab treatment for gastric cancer
por: Hagi, Takaomi, et al.
Publicado: (2020)

Specific activation of glycolytic enzyme enolase 2 in BRAF V600E‐mutated colorectal cancer
por: Yukimoto, Ryohei, et al.
Publicado: (2021)

Establishment of a reference single-cell RNA sequencing dataset for human pancreatic adenocarcinoma
por: Chijimatsu, Ryota, et al.
Publicado: (2022)

Pancreatic Cancer and Detection Methods
por: Ungkulpasvich, Umbhorn, et al.
Publicado: (2023)

Hereditary pancreatitis model by blastocyst complementation in mouse
por: Asai, Ayumu, et al.
Publicado: (2020)

Preoperative neutrophil‐to‐lymphocyte ratio predicts healing time for postoperative pancreatic fistula after distal pancreatectomy
por: Toya, Keisuke, et al.
Publicado: (2021)

Partial hepatectomy for a patient with Rendu–Osler–Weber disease: a case report
por: Sekiguchi, Naoko, et al.
Publicado: (2023)

Enzymes of the one-carbon folate metabolism as anticancer targets predicted by survival rate analysis
por: Koseki, Jun, et al.
Publicado: (2018)

Randomized phase II study of SOX+B-mab versus SOX+C-mab in patients with previously untreated recurrent advanced colorectal cancer with wild-type KRAS (MCSGO-1107 study)
por: Nishizawa, Yujiro, et al.
Publicado: (2021)

N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiotherapy in pancreatic adenocarcinoma
por: Tatekawa, Shotaro, et al.
Publicado: (2022)

Clinicopathological significance of MYL9 expression in pancreatic ductal adenocarcinoma
por: Matsushita, Katsunori, et al.
Publicado: (2021)

A phase II study of neoadjuvant capecitabine, oxaliplatin, and irinotecan (XELOXIRI) in patients with locally advanced rectal cancer
por: Matsuda, Chu, et al.
Publicado: (2022)

Different timing and risk factors of cause-specific pancreas graft loss after simultaneous pancreas kidney transplantation
por: Tomimaru, Yoshito, et al.
Publicado: (2022)

A Four-Dimensional Organoid System to Visualize Cancer Cell Vascular Invasion
por: Yanagisawa, Kiminori, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_01122ehioa6ue37ohjhehvq8fh